�ݺ�ߣshows by User: martinhager

�ݺ�ߣshows by User: martinhager / http://www.slideshare.net/images/logo.gif �ݺ�ߣshows by User: martinhager / Sun, 09 Apr 2023 13:35:17 GMT �ݺ�ߣShare feed for �ݺ�ߣshows by User: martinhager Dr. Hager 2022 Interview Gesundhyte.de Magazine, page 29 /slideshow/interview-dr-hager-magazin-gesundhytede/257264295 ptj-010gesundhyte142022englonline-issn2748-3533220713web-230409133518-a9629ae3
A learning healthcare system could already be a reality]]>
A learning healthcare system could already be a reality]]> Sun, 09 Apr 2023 13:35:17 GMT /slideshow/interview-dr-hager-magazin-gesundhytede/257264295 martinhager@slideshare.net(martinhager) Dr. Hager 2022 Interview Gesundhyte.de Magazine, page 29 martinhager A learning healthcare system could already be a reality <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/ptj-010gesundhyte142022englonline-issn2748-3533220713web-230409133518-a9629ae3-thumbnail.jpg?width=120&height=120&fit=bounds" /> A learning healthcare system could already be a reality

Dr. Hager 2022 Interview Gesundhyte.de Magazine, page 29 from Dr. Martin Hager, MBA

]]> 57 0 https://cdn.slidesharecdn.com/ss_thumbnails/ptj-010gesundhyte142022englonline-issn2748-3533220713web-230409133518-a9629ae3-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Dr. Hager 2021 Interview Roche in Deutschland (page 3) https://de.slideshare.net/slideshow/dr-hager-2021-interview-roche-in-deutschland/250332228 roche-rid-magazin-2-20211-210929144248
Digital Patient Monitoring and Management (DPMM)]]>
Digital Patient Monitoring and Management (DPMM)]]> Wed, 29 Sep 2021 14:42:47 GMT https://de.slideshare.net/slideshow/dr-hager-2021-interview-roche-in-deutschland/250332228 martinhager@slideshare.net(martinhager) Dr. Hager 2021 Interview Roche in Deutschland (page 3) martinhager Digital Patient Monitoring and Management (DPMM) <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/roche-rid-magazin-2-20211-210929144248-thumbnail.jpg?width=120&height=120&fit=bounds" /> Digital Patient Monitoring and Management (DPMM)

from Dr. Martin Hager, MBA

]]> 254 0 https://cdn.slidesharecdn.com/ss_thumbnails/roche-rid-magazin-2-20211-210929144248-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Dr. Hager 2021 Interview https://de.slideshare.net/slideshow/interview-250264566/250264566 dok1-210922114551
Die Zukunft der Onkologie]]>
Die Zukunft der Onkologie]]> Wed, 22 Sep 2021 11:45:51 GMT https://de.slideshare.net/slideshow/interview-250264566/250264566 martinhager@slideshare.net(martinhager) Dr. Hager 2021 Interview martinhager Die Zukunft der Onkologie <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/dok1-210922114551-thumbnail.jpg?width=120&height=120&fit=bounds" /> Die Zukunft der Onkologie

from Dr. Martin Hager, MBA

]]> 44 0 https://cdn.slidesharecdn.com/ss_thumbnails/dok1-210922114551-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Dr. Hager 2020 Interview Journal Onkologie https://de.slideshare.net/slideshow/dr-hager-2020-interview-journal-onkologie/237606522 200308journalonkostudiecupisco-200806093518
Cancer of Unknown Primary]]>
Cancer of Unknown Primary]]> Thu, 06 Aug 2020 09:35:18 GMT https://de.slideshare.net/slideshow/dr-hager-2020-interview-journal-onkologie/237606522 martinhager@slideshare.net(martinhager) Dr. Hager 2020 Interview Journal Onkologie martinhager Cancer of Unknown Primary <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/200308journalonkostudiecupisco-200806093518-thumbnail.jpg?width=120&height=120&fit=bounds" /> Cancer of Unknown Primary

from Dr. Martin Hager, MBA

]]> 138 0 https://cdn.slidesharecdn.com/ss_thumbnails/200308journalonkostudiecupisco-200806093518-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Dr. Hager 2020 Interview VISION (page 21) https://de.slideshare.net/slideshow/dr-hager-2020-interview-vision-page-16/237606136 vision2020onkoratsonderausgabe-200806092015
Special Edition VISION 6/2020 ]]>
Special Edition VISION 6/2020 ]]> Thu, 06 Aug 2020 09:20:15 GMT https://de.slideshare.net/slideshow/dr-hager-2020-interview-vision-page-16/237606136 martinhager@slideshare.net(martinhager) Dr. Hager 2020 Interview VISION (page 21) martinhager Special Edition VISION 6/2020 <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/vision2020onkoratsonderausgabe-200806092015-thumbnail.jpg?width=120&height=120&fit=bounds" /> Special Edition VISION 6/2020

from Dr. Martin Hager, MBA

]]> 178 1 https://cdn.slidesharecdn.com/ss_thumbnails/vision2020onkoratsonderausgabe-200806092015-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Dr. Hager 2020 Interview Frankfurter Allgemeine Zeitung https://de.slideshare.net/martinhager/interview-dr-hager-2020-frankfurter-allgemeine-zeitung 11111111-200617122640
Frankfurter Allgemeine Zeitung Verlagsspezial 16. Juni 2020 Zukunft der Krebsmedizin]]>
Frankfurter Allgemeine Zeitung Verlagsspezial 16. Juni 2020 Zukunft der Krebsmedizin]]> Wed, 17 Jun 2020 12:26:39 GMT https://de.slideshare.net/martinhager/interview-dr-hager-2020-frankfurter-allgemeine-zeitung martinhager@slideshare.net(martinhager) Dr. Hager 2020 Interview Frankfurter Allgemeine Zeitung martinhager Frankfurter Allgemeine Zeitung Verlagsspezial 16. Juni 2020 Zukunft der Krebsmedizin <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/11111111-200617122640-thumbnail.jpg?width=120&height=120&fit=bounds" /> Frankfurter Allgemeine Zeitung Verlagsspezial 16. Juni 2020 Zukunft der Krebsmedizin

from Dr. Martin Hager, MBA

]]> 94 0 https://cdn.slidesharecdn.com/ss_thumbnails/11111111-200617122640-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Dr. Hager 2019 Interview Bilanz Das Deutsche Wirtschaftsmagazin https://de.slideshare.net/slideshow/dr-hager-2019-interview-bilanz-das-deutsche-wirtschaftsmagazin/226161308 bilanzdasdeutschewirtschaftsmagazinkiistkeinluxusmehr-200130145036
Künstliche Intelligenz ist kein Luxus mehr]]>
Künstliche Intelligenz ist kein Luxus mehr]]> Thu, 30 Jan 2020 14:50:36 GMT https://de.slideshare.net/slideshow/dr-hager-2019-interview-bilanz-das-deutsche-wirtschaftsmagazin/226161308 martinhager@slideshare.net(martinhager) Dr. Hager 2019 Interview Bilanz Das Deutsche Wirtschaftsmagazin martinhager Künstliche Intelligenz ist kein Luxus mehr <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/bilanzdasdeutschewirtschaftsmagazinkiistkeinluxusmehr-200130145036-thumbnail.jpg?width=120&height=120&fit=bounds" /> Künstliche Intelligenz ist kein Luxus mehr

from Dr. Martin Hager, MBA

]]> 108 1 https://cdn.slidesharecdn.com/ss_thumbnails/bilanzdasdeutschewirtschaftsmagazinkiistkeinluxusmehr-200130145036-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Dr. Hager 2016 Presentation The Challenges of Achieving Early Efficacy in Clinical Development /slideshow/the-challenges-of-achieving-early-efficacy-in-clinical-development/226153385 dr-200130142204
Dr. Hager Presentation 2016]]>
Dr. Hager Presentation 2016]]> Thu, 30 Jan 2020 14:22:03 GMT /slideshow/the-challenges-of-achieving-early-efficacy-in-clinical-development/226153385 martinhager@slideshare.net(martinhager) Dr. Hager 2016 Presentation The Challenges of Achieving Early Efficacy in Clinical Development martinhager Dr. Hager Presentation 2016 <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/dr-200130142204-thumbnail.jpg?width=120&height=120&fit=bounds" /> Dr. Hager Presentation 2016

Dr. Hager 2016 Presentation The Challenges of Achieving Early Efficacy in Clinical Development from Dr. Martin Hager, MBA

]]> 140 0 https://cdn.slidesharecdn.com/ss_thumbnails/dr-200130142204-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Dr. Hager 2018 presentation Roche media event ESMO https://de.slideshare.net/slideshow/dr-hager-2018-presentation-roche-media-event-esmo/164478427 presentationdr-190817170130
press conference ]]>
press conference ]]> Sat, 17 Aug 2019 17:01:30 GMT https://de.slideshare.net/slideshow/dr-hager-2018-presentation-roche-media-event-esmo/164478427 martinhager@slideshare.net(martinhager) Dr. Hager 2018 presentation Roche media event ESMO martinhager press conference <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/presentationdr-190817170130-thumbnail.jpg?width=120&height=120&fit=bounds" /> press conference

from Dr. Martin Hager, MBA

]]> 185 2 https://cdn.slidesharecdn.com/ss_thumbnails/presentationdr-190817170130-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Dr. Hager 2018 presentation: Roche PHC 2.0 press conference https://de.slideshare.net/slideshow/dr-hager-2018-presentation-roche-phc-20-press-conference/117249047 vortragrochepressekonferenz11-180929055917
Press conference: From stratification to precision medicine - Roche Pharma AG and personalized healthcare 2.0]]>
Press conference: From stratification to precision medicine - Roche Pharma AG and personalized healthcare 2.0]]> Sat, 29 Sep 2018 05:59:17 GMT https://de.slideshare.net/slideshow/dr-hager-2018-presentation-roche-phc-20-press-conference/117249047 martinhager@slideshare.net(martinhager) Dr. Hager 2018 presentation: Roche PHC 2.0 press conference martinhager Press conference: From stratification to precision medicine - Roche Pharma AG and personalized healthcare 2.0 <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/vortragrochepressekonferenz11-180929055917-thumbnail.jpg?width=120&height=120&fit=bounds" /> Press conference: From stratification to precision medicine - Roche Pharma AG and personalized healthcare 2.0

from Dr. Martin Hager, MBA

]]> 460 12 https://cdn.slidesharecdn.com/ss_thumbnails/vortragrochepressekonferenz11-180929055917-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Dr. Hager 2018 Interview "Im Focus Onkologie" https://de.slideshare.net/slideshow/dr-hager-2018-interview-im-focus-onkologie/112682331 1501520182107mpresentation-180902171423
CUPISCO Study p.79]]>
CUPISCO Study p.79]]> Sun, 02 Sep 2018 17:14:23 GMT https://de.slideshare.net/slideshow/dr-hager-2018-interview-im-focus-onkologie/112682331 martinhager@slideshare.net(martinhager) Dr. Hager 2018 Interview "Im Focus Onkologie" martinhager CUPISCO Study p.79 <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/1501520182107mpresentation-180902171423-thumbnail.jpg?width=120&height=120&fit=bounds" /> CUPISCO Study p.79

from Dr. Martin Hager, MBA

]]> 800 8 https://cdn.slidesharecdn.com/ss_thumbnails/1501520182107mpresentation-180902171423-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 MBA Practicum: Global Venture Capital /slideshow/global-venture-capital/71506516 mbapracticum-160709122826-170129093713
A Comparison of the Venture Capital Industries in the USA, Japan and Germany]]>
A Comparison of the Venture Capital Industries in the USA, Japan and Germany]]> Sun, 29 Jan 2017 09:37:13 GMT /slideshow/global-venture-capital/71506516 martinhager@slideshare.net(martinhager) MBA Practicum: Global Venture Capital martinhager A Comparison of the Venture Capital Industries in the USA, Japan and Germany <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/mbapracticum-160709122826-170129093713-thumbnail.jpg?width=120&height=120&fit=bounds" /> A Comparison of the Venture Capital Industries in the USA, Japan and Germany

MBA Practicum: Global Venture Capital from Dr. Martin Hager, MBA

]]> 728 8 https://cdn.slidesharecdn.com/ss_thumbnails/mbapracticum-160709122826-170129093713-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Dr. Martin H. Hager IMPaCT Conference Orlando /slideshow/impact-conference-orlando-dr-martin-h-hager/54609662 impactconferencedr-151101072539-lva1-app6891
Innovative Minds in Prostate Cancer Today IMPaCT Conference Congressionally Directed Medical Research Program of the U.S. Department of Defense Dr. Martin H. Hager presentation New treatment strategies Angiogenesis, Invasion, Metastasis Martin H. Hager Targeted Therapy Cancer Angiogenesis Metastasis]]>
Innovative Minds in Prostate Cancer Today IMPaCT Conference Congressionally Directed Medical Research Program of the U.S. Department of Defense Dr. Martin H. Hager presentation New treatment strategies Angiogenesis, Invasion, Metastasis Martin H. Hager Targeted Therapy Cancer Angiogenesis Metastasis]]> Sun, 01 Nov 2015 07:25:39 GMT /slideshow/impact-conference-orlando-dr-martin-h-hager/54609662 martinhager@slideshare.net(martinhager) Dr. Martin H. Hager IMPaCT Conference Orlando martinhager Innovative Minds in Prostate Cancer Today IMPaCT Conference Congressionally Directed Medical Research Program of the U.S. Department of Defense Dr. Martin H. Hager presentation New treatment strategies Angiogenesis, Invasion, Metastasis Martin H. Hager Targeted Therapy Cancer Angiogenesis Metastasis <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/impactconferencedr-151101072539-lva1-app6891-thumbnail.jpg?width=120&height=120&fit=bounds" /> Innovative Minds in Prostate Cancer Today IMPaCT Conference Congressionally Directed Medical Research Program of the U.S. Department of Defense Dr. Martin H. Hager presentation New treatment strategies Angiogenesis, Invasion, Metastasis Martin H. Hager Targeted Therapy Cancer Angiogenesis Metastasis

Dr. Martin H. Hager IMPaCT Conference Orlando from Dr. Martin Hager, MBA

]]> 550 7 https://cdn.slidesharecdn.com/ss_thumbnails/impactconferencedr-151101072539-lva1-app6891-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Dr. Hager Scholarship at Harvard (2012) /slideshow/hager-mh-et-al-embo-molecular-medicine/42291107 hagermhetal-141203002341-conversion-gate01
DIAPH3 governs mesenchymal amoeboid transition The Amoeboid Tumor Phenotype]]>
DIAPH3 governs mesenchymal amoeboid transition The Amoeboid Tumor Phenotype]]> Wed, 03 Dec 2014 00:23:41 GMT /slideshow/hager-mh-et-al-embo-molecular-medicine/42291107 martinhager@slideshare.net(martinhager) Dr. Hager Scholarship at Harvard (2012) martinhager DIAPH3 governs mesenchymal amoeboid transition The Amoeboid Tumor Phenotype <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/hagermhetal-141203002341-conversion-gate01-thumbnail.jpg?width=120&height=120&fit=bounds" /> DIAPH3 governs mesenchymal amoeboid transition The Amoeboid Tumor Phenotype

Dr. Hager Scholarship at Harvard (2012) from Dr. Martin Hager, MBA

]]> 817 7 https://cdn.slidesharecdn.com/ss_thumbnails/hagermhetal-141203002341-conversion-gate01-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Dr. Hager 2014 interview, Daiichi Sankyo Co. Ltd. (page 64) /slideshow/interview-with-dr-hager-page-64-2014/41692506 interviewwithdr-141118034933-conversion-gate02
Interview with Dr. Hager in Daiichi-Sankyo Corporate Value Report 2014 Leadership Fostering Leaders ]]>
Interview with Dr. Hager in Daiichi-Sankyo Corporate Value Report 2014 Leadership Fostering Leaders ]]> Tue, 18 Nov 2014 03:49:32 GMT /slideshow/interview-with-dr-hager-page-64-2014/41692506 martinhager@slideshare.net(martinhager) Dr. Hager 2014 interview, Daiichi Sankyo Co. Ltd. (page 64) martinhager Interview with Dr. Hager in Daiichi-Sankyo Corporate Value Report 2014 Leadership Fostering Leaders <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/interviewwithdr-141118034933-conversion-gate02-thumbnail.jpg?width=120&height=120&fit=bounds" /> Interview with Dr. Hager in Daiichi-Sankyo Corporate Value Report 2014 Leadership Fostering Leaders

Dr. Hager 2014 interview, Daiichi Sankyo Co. Ltd. (page 64) from Dr. Martin Hager, MBA

]]> 1217 7 https://cdn.slidesharecdn.com/ss_thumbnails/interviewwithdr-141118034933-conversion-gate02-thumbnail.jpg?width=120&height=120&fit=bounds document White http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Dr. Hager 2012 interview Daiichi Sankyo Co. Ltd. /slideshow/interview-with-dr-hager-page-11-english/39827690 interviewwithdr-141003004933-phpapp02
Daiichi-Sankyo Global Corporate Journal DS-6051 ROS1 inhibitor NTRK inhibitor]]>
Daiichi-Sankyo Global Corporate Journal DS-6051 ROS1 inhibitor NTRK inhibitor]]> Fri, 03 Oct 2014 00:49:33 GMT /slideshow/interview-with-dr-hager-page-11-english/39827690 martinhager@slideshare.net(martinhager) Dr. Hager 2012 interview Daiichi Sankyo Co. Ltd. martinhager Daiichi-Sankyo Global Corporate Journal DS-6051 ROS1 inhibitor NTRK inhibitor <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/interviewwithdr-141003004933-phpapp02-thumbnail.jpg?width=120&height=120&fit=bounds" /> Daiichi-Sankyo Global Corporate Journal DS-6051 ROS1 inhibitor NTRK inhibitor

Dr. Hager 2012 interview Daiichi Sankyo Co. Ltd. from Dr. Martin Hager, MBA

]]> 2417 5 https://cdn.slidesharecdn.com/ss_thumbnails/interviewwithdr-141003004933-phpapp02-thumbnail.jpg?width=120&height=120&fit=bounds presentation White http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 https://cdn.slidesharecdn.com/profile-photo-martinhager-48x48.jpg?cb=1709393932 www.linkedin.com/in/martinhager1 https://cdn.slidesharecdn.com/ss_thumbnails/ptj-010gesundhyte142022englonline-issn2748-3533220713web-230409133518-a9629ae3-thumbnail.jpg?width=320&height=320&fit=bounds slideshow/interview-dr-hager-magazin-gesundhytede/257264295 Dr. Hager 2022 Intervi... https://cdn.slidesharecdn.com/ss_thumbnails/roche-rid-magazin-2-20211-210929144248-thumbnail.jpg?width=320&height=320&fit=bounds slideshow/dr-hager-2021-interview-roche-in-deutschland/250332228 Dr. Hager 2021 Intervi... https://cdn.slidesharecdn.com/ss_thumbnails/dok1-210922114551-thumbnail.jpg?width=320&height=320&fit=bounds slideshow/interview-250264566/250264566 Dr. Hager 2021 Interview